Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting.

Levine D, Patel MD, Suh-Burgmann EJ, Andreotti RF, Benacerraf BR, Benson CB, Brewster WR, Coleman BG, Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow MM, Hur HC, Marnach ML, Pavlik E, Platt LD, Puscheck E, Smith-Bindman R, Brown DL.

Radiology. 2019 Nov;293(2):359-371. doi: 10.1148/radiol.2019191354. Epub 2019 Sep 24.

PMID:
31549945
2.

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.

Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, Mannel RS, Kim JW, Salani R, DiSilvestro PA, Burke JJ, Rutherford T, Spirtos NM, Terada K, Anderson PR, Brewster WR, Small W, Aghajanian CA, Miller DS.

J Clin Oncol. 2019 Jul 20;37(21):1810-1818. doi: 10.1200/JCO.18.01575. Epub 2019 Apr 17.

3.

Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.

Spees LP, Brewster WR, Varia MA, Weinberger M, Baggett C, Zhou X, Petermann VM, Wheeler SB.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):882-889. doi: 10.1158/1055-9965.EPI-18-0945. Epub 2019 Feb 7.

PMID:
30733307
4.

Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.

Spees LP, Wheeler SB, Varia M, Weinberger M, Baggett CD, Zhou X, Petermann VM, Brewster WR.

Gynecol Oncol. 2019 Jan;152(1):112-118. doi: 10.1016/j.ygyno.2018.11.010. Epub 2018 Nov 12.

PMID:
30442384
5.

Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report.

Rauh-Hain JA, Brewster WR, Behbakht K.

Gynecol Oncol. 2018 Nov;151(2):e7-e9. doi: 10.1016/j.ygyno.2018.08.019. Epub 2018 Aug 24. No abstract available.

PMID:
30146111
6.

DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.

Gomih A, Smith JS, North KE, Hudgens MG, Brewster WR, Huang Z, Skaar D, Valea F, Bentley RC, Vidal AC, Maguire RL, Jirtle RL, Murphy SK, Hoyo C.

Int J Cancer. 2018 Aug 1;143(3):552-560. doi: 10.1002/ijc.31350. Epub 2018 Mar 30.

7.

For U.S. Black women, shift of hysterectomy to outpatient settings may have lagged behind White women: a claims-based analysis, 2011-2013.

Robinson WR, Cheng MM, Howard AG, Carpenter WR, Brewster WR, Doll KM.

BMC Health Serv Res. 2017 Aug 4;17(1):526. doi: 10.1186/s12913-017-2471-1.

8.

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.

Skates SJ, Greene MH, Buys SS, Mai PL, Brown P, Piedmonte M, Rodriguez G, Schorge JO, Sherman M, Daly MB, Rutherford T, Brewster WR, O'Malley DM, Partridge E, Boggess J, Drescher CW, Isaacs C, Berchuck A, Domchek S, Davidson SA, Edwards R, Elg SA, Wakeley K, Phillips KA, Armstrong D, Horowitz I, Fabian CJ, Walker J, Sluss PM, Welch W, Minasian L, Horick NK, Kasten CH, Nayfield S, Alberts D, Finkelstein DM, Lu KH.

Clin Cancer Res. 2017 Jul 15;23(14):3628-3637. doi: 10.1158/1078-0432.CCR-15-2750. Epub 2017 Jan 31.

9.

Clinical Benefits Associated With Medicaid Coverage Before Diagnosis of Gynecologic Cancers.

Doll KM, Basch EM, Meng K, Barber EL, Gehrig PA, Brewster WR, Meyer AM.

J Oncol Pract. 2016 Jun;12(6):e724-33. doi: 10.1200/JOP.2016.011080. Epub 2016 May 31.

10.

Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.

Doll KM, Meng K, Gehrig PA, Brewster WR, Meyer AM.

Am J Obstet Gynecol. 2016 Oct;215(4):447.e1-447.e13. doi: 10.1016/j.ajog.2016.04.020. Epub 2016 Apr 26.

11.

Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer.

Giovinazzo H, Kumar P, Sheikh A, Brooks KM, Ivanovic M, Walsh M, Caron WP, Kowalsky RJ, Song G, Whitlow A, Clarke-Pearson DL, Brewster WR, Van Le L, Zamboni BA, Bae-Jump V, Gehrig PA, Zamboni WC.

Cancer Chemother Pharmacol. 2016 Mar;77(3):565-73. doi: 10.1007/s00280-015-2945-y. Epub 2016 Jan 28.

PMID:
26822231
12.

Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.

Rim SH, Hirsch S, Thomas CC, Brewster WR, Cooney D, Thompson TD, Stewart SL.

World J Obstet Gynecol. 2016;5(2):187-196. doi: 10.5317/wjog.v5.i2.187. Epub 2016 May 10.

13.

Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian Cancer.

Barber EL, Boggess JF, Van Le L, Kim KH, Bae-Jump VL, Brewster WR, Soper JT, Gehrig PA.

Obstet Gynecol. 2015 Dec;126(6):1191-7. doi: 10.1097/AOG.0000000000001138.

PMID:
26551182
14.

Gynecologic cancer outcomes in the elderly poor: A population-based study.

Doll KM, Meng K, Basch EM, Gehrig PA, Brewster WR, Meyer AM.

Cancer. 2015 Oct 15;121(20):3591-9. doi: 10.1002/cncr.29541. Epub 2015 Jul 31.

15.

Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk?

Doll KM, Snavely AC, Kalinowski A, Irwin DE, Bensen JT, Bae-Jump V, Boggess JF, Soper JT, Brewster WR, Gehrig PA.

Gynecol Oncol. 2014 Jun;133(3):546-51. doi: 10.1016/j.ygyno.2014.04.002. Epub 2014 Apr 12.

16.

Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.

Caron WP, Lay JC, Fong AM, La-Beck NM, Kumar P, Newman SE, Zhou H, Monaco JH, Clarke-Pearson DL, Brewster WR, Van Le L, Bae-Jump VL, Gehrig PA, Zamboni WC.

J Pharmacol Exp Ther. 2013 Dec;347(3):599-606. doi: 10.1124/jpet.113.208801. Epub 2013 Sep 16.

17.

Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.

Doll KM, Stine JE, Van Le L, Moore DT, Bae-Jump V, Brewster WR, Soper JT, Boggess JF, Gehrig PA, Kim KH.

Gynecol Oncol. 2013 Jul;130(1):152-5. doi: 10.1016/j.ygyno.2013.03.020. Epub 2013 Mar 29.

PMID:
23542684
18.

Did GOG99 and PORTEC1 change clinical practice in the United States?

Ko EM, Funk MJ, Clark LH, Brewster WR.

Gynecol Oncol. 2013 Apr;129(1):12-7. doi: 10.1016/j.ygyno.2013.01.020. Epub 2013 Jan 29.

PMID:
23376807
19.

Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?

Chase DM, Fedewa S, Chou TS, Chen A, Ward E, Brewster WR.

Obstet Gynecol. 2012 Jan;119(1):68-77. doi: 10.1097/AOG.0b013e31823d4006.

PMID:
22183213
20.

Summary of the 2011 Annual Meeting on Women's Cancers.

Brewster WR, Cliby W.

Gynecol Oncol. 2011 Jul;122(1):5-8. doi: 10.1016/j.ygyno.2011.03.029. Epub 2011 May 4. No abstract available.

PMID:
21546067
21.

Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement.

Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, Coleman B, DePriest P, Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow M, Hur HC, Marnach M, Patel MD, Platt LD, Puscheck E, Smith-Bindman R; Society of Radiologists in Ultrasound.

Ultrasound Q. 2010 Sep;26(3):121-31. doi: 10.1097/RUQ.0b013e3181f09099. Review.

PMID:
20823748
22.

Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement.

Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, Coleman B, Depriest P, Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow M, Hur HC, Marnach M, Patel MD, Platt LD, Puscheck E, Smith-Bindman R.

Radiology. 2010 Sep;256(3):943-54. doi: 10.1148/radiol.10100213. Epub 2010 May 26. Review.

PMID:
20505067
23.

Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma.

Chase DM, Rincon A, Deane M, Tewari KS, Brewster WR.

Gynecol Oncol. 2009 Dec;115(3):339-42. doi: 10.1016/j.ygyno.2009.08.008. Epub 2009 Sep 22.

24.

Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.

Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, Gentry-Maharaj A, Jacobs IJ, Webb PM, Beesley J, Chen X; Australian Cancer (Ovarian) Study; Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Ness RB, Moysich K, Goode EL, Vierkant RA, Cunningham JM, Anderson S, Schildkraut JM, Berchuck A, Iversen ES, Moorman PG, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Anton-Culver H, Ziogas A, Brewster WR, Ponder BA, Easton DF, Gayther SA, Pharoah PD; Ovarian Cancer Association Consortium (OCAC).

Hum Mol Genet. 2009 Jun 15;18(12):2297-304. doi: 10.1093/hmg/ddp138. Epub 2009 Mar 20.

25.

The complexity of race in the disparate outcome and treatment of minority patients.

Brewster WR.

Gynecol Oncol. 2008 Nov;111(2):161-2. doi: 10.1016/j.ygyno.2008.10.001. No abstract available.

PMID:
19006712
26.

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.

Gynecol Oncol. 2009 Jan;112(1):85-9. doi: 10.1016/j.ygyno.2008.09.029. Epub 2008 Nov 1.

27.

Could a pelvic and abdominal symptom index assist in early detection of ovarian cancer?

Brewster WR.

Nat Clin Pract Oncol. 2007 Jun;4(6):338-9. Epub 2007 May 1. No abstract available.

PMID:
17471282
28.

Day-3 embryo morphology predicts euploidy among older subjects.

Moayeri SE, Allen RB, Brewster WR, Kim MH, Porto M, Werlin LB.

Fertil Steril. 2008 Jan;89(1):118-23. Epub 2007 Apr 23.

PMID:
17451697
29.
30.

Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Maxwell GL, Tian C, Risinger J, Brown CL, Rose GS, Thigpen JT, Fleming GF, Gallion HH, Brewster WR; Gynecologic Oncology Group study.

Cancer. 2006 Nov 1;107(9):2197-205.

31.

p16-Positive small cell neuroendocrine carcinoma of the endometrium.

Melgoza F, Brewster WR, Wilczynski S, Rutgers J.

Int J Gynecol Pathol. 2006 Jul;25(3):252-6.

PMID:
16810063
32.

Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening.

Theuer CP, Taylor TH, Brewster WR, Anton-Culver H.

J Natl Med Assoc. 2006 Jan;98(1):51-7.

33.

Temporal trends in ovarian cancer: incidence and mortality across Europe.

Brewster WR.

Nat Clin Pract Oncol. 2005 Jun;2(6):286-7. No abstract available.

PMID:
16264981
34.

Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.

Brewster WR, Hubbell FA, Largent J, Ziogas A, Lin F, Howe S, Ganiats TG, Anton-Culver H, Manetta A.

JAMA. 2005 Nov 2;294(17):2182-7.

PMID:
16264159
35.

Population characteristics in cervical cancer trials: search for external validity.

Yessaian A, Mendivil AA, Brewster WR.

Am J Obstet Gynecol. 2005 Feb;192(2):407-13.

PMID:
15695979
36.

Untreated cervical cancer.

Brewster WR.

Gynecol Oncol. 2005 Feb;96(2):269-70. No abstract available.

PMID:
15661206
37.
38.

Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?

Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ.

Obstet Gynecol. 2003 Jul;102(1):156-61.

PMID:
12850623
39.

Does the ALTS trial apply to the community-based practitioner?

Monk BJ, Brewster WR.

Am J Obstet Gynecol. 2003 Jun;188(6):1381-2. No abstract available.

PMID:
12824966
40.

Recruitment strategies for cervical cancer prevention study.

Brewster WR, Anton-Culver H, Ziogas A, Largent J, Howe S, Hubbell FA, Manetta A.

Gynecol Oncol. 2002 May;85(2):250-4.

PMID:
11972383
41.

Hormone replacement therapy for survivors of breast and endometrial cancer.

DiSaia PJ, Brewster WR.

Curr Oncol Rep. 2002 Mar;4(2):152-8. Review.

PMID:
11822987
42.

The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy.

Theuer CP, Taylor TH, Brewster WR, Campbell BS, Becerra JC, Anton-Culver H.

Am Surg. 2001 Dec;67(12):1157-61.

PMID:
11768820
43.

Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States.

Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, Anton-Culver H.

Gastroenterology. 2001 Mar;120(4):848-56.

44.

Breast cancer survival and hormone replacement therapy: a cohort analysis.

DiSaia PJ, Brewster WR, Ziogas A, Anton-Culver H.

Am J Clin Oncol. 2000 Dec;23(6):541-5.

PMID:
11202792
45.

Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995.

Brewster WR, Monk BJ, Ziogas A, Anton-Culver H, Yamada SD, Berman ML.

Obstet Gynecol. 2001 Feb;97(2):248-54.

PMID:
11165590
46.

A randomized controlled trial of the effect of increased intravenous hydration on the course of labor in nulliparous women.

Garite TJ, Weeks J, Peters-Phair K, Pattillo C, Brewster WR.

Am J Obstet Gynecol. 2000 Dec;183(6):1544-8.

PMID:
11120525
47.

Hormone replacement therapy in breast cancer survivors.

Disaia PJ, Brewster WR.

Am J Obstet Gynecol. 2000 Aug;183(2):517. No abstract available.

PMID:
10942510
48.

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus.

Yamada SD, Burger RA, Brewster WR, Anton D, Kohler MF, Monk BJ.

Cancer. 2000 Jun 15;88(12):2782-6.

PMID:
10870061
49.

Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival.

Theuer CP, Nastanski F, Brewster WR, Butler JA, Anton-Culver H.

Am Surg. 1999 Oct;65(10):915-21.

PMID:
10515534
50.

Does human papillomavirus have a role in cancers of the uterine corpus?

Brewster WR, Monk BJ, Burger RA, Bergen S, Wilczynski SP.

Gynecol Oncol. 1999 Oct;75(1):51-4. Review.

PMID:
10502425

Supplemental Content

Loading ...
Support Center